Evidence map›Paper›PMID 30301179›Full record

ArticleJournal of clinical medicine2018

Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration.

Suzanne M Ingle, Heidi M Crane, Tracy R Glass, Benita Yip, Viviane D Lima, M John Gill, Nikola Hanhoff, Adriana Ammassari, Michael J Mugavero, Jan P Tate and 4 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Suzanne M InglePopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK. s.ingle@bristol.ac.uk.ORCID 0000-0003-3057-6636
Heidi M CraneClinical Epidemiology and Health Services Research Core, Center for AIDS Research, University of Washington, WA 98104, USA. hcrane@uw.edu.
Tracy R GlassSwiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland. tracy.glass@swisstph.ch.
Benita YipBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada. byip@cfenet.ubc.ca.
Viviane D LimaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada. vlima@cfenet.ubc.ca.
M John GillDivision of Infectious Diseases, University of Calgary, Calgary, AB T2N 4N1, Canada. john.gill@albertahealthservices.ca.ORCID 0000-0002-8546-8790
Nikola HanhoffSouthern Alberta Clinic, Calgary, AB T2R 0X7, Canada. nikola@hanhoff.com.
Adriana AmmassariIstituto Nazionale Malattie Infettive "L. Spallanzani", IRCCS, 00149 Rome, Italy. adriana.ammassari@inmi.it.
Michael J MugaveroDivision of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL 35294, USA. mmugavero@uab.edu.
Jan P TateYale University School of Medicine, West Haven, CT 06510, USA. Janet.Tate2@va.gov.
Jodie GuestHIV Atlanta VA Cohort Study (HAVACS), Rollins School of Public Health at Emory University, Atlanta, GA 30322, USA. jodie.guest@emory.edu.
Nicholas L TurnerPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK. nicholas.turner@bristol.ac.uk.
Margaret T MayPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK. margaret.may@bristol.ac.uk.
Jonathan A C SternePopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK. jonathan.sterne@bristol.ac.uk.ORCID 0000-0001-8496-6053

Funding

Medical Research Council G0100221Medical Research Council G0700820Medical Research Council MR/J002380/1
6 · The paper itself

Abstract

Adherence to antiretroviral therapy (ART) is critical for successful treatment of Human Immunodeficiency Virus (HIV), but comparisons across settings are difficult because adherence is measured in different ways. We examined utility of different adherence measures for identification of patients at risk of viral failure (VF). Eight cohorts in the ART Cohort Collaboration contributed data from pharmacy refills or self-report questionnaires collected between 1996 and 2013 (

Indexed as

adherenceantiretroviral therapycohort studiesHIVviral failure

Identifiers

PMID30301179
PMCPMC6209956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.